NIAID R24 Guide 2026: Eligibility
Updated 4 official sources
Quick Answer: NIH NIAID R24 eligibility is strongest when the proposal is a true research resource for NIAID-relevant science, not a normal research project wearing a resource label.
Full answer and how we checked it
PAR-27-083 is clinical trial not allowed, allows up to 5 years, and says NIAID does not expect more than 1-2 competing awards per year. The next due date is January 25, 2027 (the September 25, 2026 date has passed), and the announcement expires May 26, 2029.
Who this is for: Principal investigators, core directors, research offices, and infectious-disease teams deciding whether an NIAID resource-related project belongs on R24 or a different NIH route.
Data note: This guide uses NIH PAR-27-083, NIH R24 activity guidance, the live NIAID R24 program page, and USAspending data, checked again on October 9, 2026.
In this guide
The NIAID R24 is not a backdoor R01. According to NIH PAR-27-083, the opportunity supports resource-related research projects and does not accept clinical trials. The practical question is whether the proposed work will create or maintain something other investigators can use, and whether that resource is important to NIAID's mission.
Use this guide with the live NIAID Resource-Related Research Projects R24 page. Then compare broader route choices in NIH R01, R21, R03, and K awards, NIH grants complete guide, and how grant reviewers score applications.
Resource concepts can fail because the team describes a strong project but not a shared resource. That distinction matters here.
From Manusights, our sister product
Applying for an R01 or R21? Manusights offers an AI critique of your application against NIH's published review criteria: $149 for a new R01 or R21, $199 for a resubmission. Back within 3 business days of your upload.
Order a grant reviewNIH NIAID R24 Eligibility: 3 Screens
5 years is the maximum project period, so 3 screens should happen before writing. PAR-27-083 lists broad eligible U.S. applicant organization types, including higher education, nonprofits, for-profits, governments, tribal organizations, and faith-based or community-based organizations. Foreign organizations and non-U.S. components of U.S. organizations are not eligible, and applications with foreign subawards are deemed noncompliant, though foreign components are allowed. That broad domestic eligibility can mislead teams into underweighting program fit.
| Screen | Strong R24 answer | Red flag |
|---|---|---|
| Resource value | Other NIAID-relevant researchers can use the output | Only the applicant's lab benefits |
| Mission fit | Infectious, immunologic, allergic, or immune-mediated disease relevance is clear | NIAID relevance is asserted late |
| No clinical trial | Human-subject activity is not an NIH-defined clinical trial | Intervention testing drives the project |
The strongest R24 ideas usually have a service, repository, dataset, model, reagent, method base, or platform that changes what a field can do. The weak version is a research plan that happens to generate data.
Get research funding calls by email
About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.
No spam. Unsubscribe anytime.
Clinical-Trial Not Allowed Means Stop Early
5 years can be requested under PAR-27-083, but clinical-trial status should be decided before the team spends proposal time. The announcement says the opportunity accepts only applications that do not propose clinical trials, while human-subject activities that are not deemed clinical trials may be proposed.
| Proposed activity | Likely issue |
|---|---|
| Collect specimens for a repository with no intervention assignment | Possible if all human-subject rules are met |
| Build and share pathogen, immunology, or allergy datasets | Possible if resource value is clear |
| Test a treatment, prevention, or diagnostic intervention prospectively | Likely outside this NOFO |
| Run a trial site network | Not this R24 unless the notice allows the role |
According to PAR-27-083, funds are very limited and NIAID does not expect more than 1-2 competing awards per year. According to USAspending.gov (opens in a new tab) data, Assistance Listing 93.855, which covers nearly all NIAID research grants, had about $4.15 billion in FY2024 grant obligations. That is an institute-wide figure, not a signal about this R24 route. Grantsights checked PAR-27-083 against those USAspending FY2024 obligation records, and Grantsights analysis of the two sources points one way: the money pool is large, but this route is built for 1-2 new awards a year.
R24 vs R01, U24, R21, and Contracts
5 years of possible support does not make R24 the right mechanism, so 4 neighboring routes often need to be ruled out. R01 funds a research project. R21 funds exploratory work. U24 or cooperative-agreement routes may fit if NIH staff involvement is built into the project. A contract may fit when NIAID is buying a defined service or product.
| Route | Better first read when... | Why |
|---|---|---|
| NIAID R24 | A shared resource is the central product | Resource value drives review |
| R01 | The applicant's hypothesis is the main product | Standard research-project logic fits |
| R21 | Early idea needs limited proof | Scope is smaller |
| U24 | Program staff coordination is expected | Cooperative structure may be needed |
| Contract | Government needs a defined service | Procurement may fit better |
For broader mechanism choice, see NIH grant types comparison. For current source links and the public grant record, use the NIAID R24 program page.
What NIH Doesn't Tell You
About $4.15 billion in FY2024 NIAID grant obligations can look encouraging, but 1-2 competing awards per year is the warning most teams should take seriously. NIH gives the public rules, but it does not tell an applicant whether the resource is field-level enough to be worth a submission.
First, NIH does not score the audience for the resource before submission. A draft can make the resource sound useful while leaving the user base implied rather than proven. A strong R24 should explain who will use the resource, why they cannot get it elsewhere, and how usage will be tracked.
Second, NIH does not tell you when the project is really an R01. If most of the work tests the applicant's hypothesis and the "resource" is just a database created at the end, that is a weak R24 posture.
Third, NIH does not solve sustainability. A resource can win initial support and still become a liability if the team has no model for access, curation, quality control, and post-award maintenance.
Fourth, NIH does not put the institute-wide money next to the route-level odds. USAspending shows a very large NIAID assistance listing, but PAR-27-083 itself says the award count for this route is expected to be small. The honest read is that NIAID is well-funded while this R24 route is selective.
The common mistake is calling something a resource because it produces data. That can lose points. A real resource changes another investigator's work.
5 Hypothetical NIAID R24 Scenarios
5 hypothetical scenarios show where the line sits. For example, one university that maintains a curated pathogen reagent resource used by many immunology labs could be R24-shaped. An investigator who proposes a normal mechanistic study that stores specimens for later use is probably R01-shaped.
| Scenario | Better route | Why |
|---|---|---|
| Field resource with known external users | R24 | Shared use is central |
| Lab-owned dataset for one hypothesis | R01 | Research question is central |
| Early tool with limited use evidence | R21 | Needs proof first |
| National service with NIH staff coordination | U24 or contract | Structure may need more agency involvement |
| Human-subject intervention study | Different clinical-trial route | R24 bars clinical trials |
A center that runs a standardized immune-reagent facility, tracks outside users, and documents data quality has a strong R24 story. A PI who proposes to enroll patients and test an intervention while producing a dataset should stop at the clinical-trial screen.
Draft Checks to Run First
1-2 expected competing awards means 7 checks should be finished before the application calendar starts. NIAID strongly encourages consultation with its staff at least 10 weeks before the due date, which for January 25, 2027 means mid-November 2026. If you can't answer these cleanly, don't treat broad organization eligibility as a reason to keep writing.
- Name the resource in 1 sentence.
- Name the users outside the applicant team.
- State how access, quality control, and updates will work.
- Prove NIAID mission fit in the opening page.
- Confirm no NIH-defined clinical trial is proposed.
- Compare R24 against R01, R21, U24, and contracts.
- Check whether the expected 1-2 awards per year makes the submission worth it.
According to NIH PAR-27-083, budgets must reflect actual project needs and may vary by scope. The announcement also says the resource must provide a significant benefit to currently funded high-priority projects, so the route decision should start with the resource value and the clinical-trial bar.
8 Resource Questions Before Writing
8 questions can save the team from a weak R24 submission. The first question is whether the resource exists for a community or only for the applicant. If the main users sit inside the same lab, center, or consortium, reviewers may see a research project with internal infrastructure rather than a field resource.
The second question is whether the resource solves an NIAID-relevant bottleneck. Infectious disease, immunology, allergy, and immune-mediated disease relevance should be visible in the first page. If NIAID fit appears only in a later significance paragraph, the application is starting too slowly.
The third question is whether access rules are ready. Who can use the resource? Will access be open, reviewed, fee-based, or limited by material transfer rules? How long will a request take? If the answer is "we'll decide after funding," the plan isn't ready.
The fourth question is quality. Reagents, datasets, model systems, and services all need quality checks. If quality assurance reads like an afterthought, reviewers can lose confidence quickly.
The fifth question is maintenance. A resource that works in year 1 but decays by year 4 is not a good R24 investment. According to NIH PAR-27-083, the maximum project period is 5 years, so the maintenance plan should cover the whole period, not just launch.
The sixth question is user evidence. Letters, usage history, pilot access, citation patterns, or documented requests can all help. The best evidence is specific: named users, named use cases, and named barriers the resource removes.
The seventh question is whether a clinical trial is hiding in the plan. NIH's decision tree should be checked before writing. Don't wait until routing to discover the project belongs elsewhere.
The eighth question is whether the budget tells a resource story. NIAID as a whole obligated about $4.15 billion in FY2024 grants under Assistance Listing 93.855, but this R24 route is still expected to make only 1-2 competing awards per year. That level of selectivity means the budget should look like a field resource, not a lab wish list.
For example, a core with documented outside users, standardized sample handling, and a clear NIAID disease connection can be credible. A PI with a useful dataset but no external request history, no access policy, and no maintenance plan should probably let the project mature before R24.
The short version: R24 is not "large R01 plus sharing." It is a resource route. If that sentence doesn't describe the project, use NIH grant types comparison and pick a cleaner mechanism.
Sources
- NIH PAR-27-083 NIAID R24 full announcement: files.simpler.grants.gov (opens in a new tab)
- NIH R24 activity code page: grants.nih.gov (opens in a new tab)
- USAspending.gov award search: usaspending.gov (opens in a new tab)
- NIH clinical-trial decision tool: grants.nih.gov (opens in a new tab)
- Grantsights NIAID R24 program page: NIAID Resource-Related Research Projects R24
Federal Program Records to Compare
Use these current program records to check eligibility, award history, deadlines, and past winners before your team commits writing time.
Frequently Asked Questions
Who is the NIAID R24 for?
The NIAID R24 is for resource-related research projects that provide, build, or maintain a research resource serving NIAID mission areas.
Does the NIAID R24 allow clinical trials?
No. PAR-27-083 is clinical trial not allowed, although human-subject activities that are not NIH-defined clinical trials may be possible.
How many NIAID R24 awards does NIAID expect?
PAR-27-083 says NIAID funds for these projects are very limited and NIAID does not expect more than 1-2 competing awards per year.
Is the NIAID R24 budget capped?
The announcement says budgets are not limited, but they must reflect the actual needs of the proposed project.
Who should skip the NIAID R24?
Skip it if the project is a standard investigator-led research study rather than a resource that other researchers can use.
Last updated October 9, 2026. Corrected October 9, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
Animal Biological Material Resource Centers P40 Guide
Animal and Biological Material guide: 7 checks for eligibility, source status, budget, evidence, route fit, and review criteria in 2026.
Funding for Community Projects 2026: 317 Funders Gave
Funding for community projects in 2026: 317 foundations made 1,048 grants for beautification, placemaking and neighborhood work. Median: $5,000. See who.
Grants for Family Resource Centers 2026: Who Pays
Grants for family resource centers in 2026: 73 foundations gave 100 youth grants to FRCs in 990-PF filings, and CBCAP money flows through 1 state agency.
Grant Timeline Examples and Template (2026)
Grant timeline examples for a 12-month program, a 3-year federal grant and an NIH R01 cycle, plus a free template you can copy into Word or Sheets.
NIAID R01 Success Rate: FY2024 and FY2025 Data
NIAID funded 15.8% of R01-equivalent applications in FY2024 by its own count, and NIH tables show 14.5% for FY2025. See paylines and FY2026 awards.
NIH P01 Grant: PA-27-061 Parent Notice and Due Dates
NIH parent P01 PA-27-061 was posted October 14, 2026: 2 to 5 linked projects, a required admin core, no budget cap. Due dates, institutes and P01 rules.